🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2018-04-10
Trial ID
NCT03540199
Treatments Being Tested
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
The purpose of this study is to find out if removing a specific type of whi...
Status
Terminated
Location
Memorial SloanKettering Cancer Center
Start Date
2018-07-23
Trial ID
NCT03615144
This Phase I Clinical Study assessed the Safety, Tolerability, Pharmacokine...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2023-03-02
Trial ID
NCT05668403
This is a single-arm, multicenter, phase II study designed to evaluate the ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-10
Trial ID
NCT07542717
Treatments Being Tested
The primary purpose of this study is to evaluate the pulse wave velocity an...
Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Start Date
2019-11-11
Trial ID
NCT03841097
Treatments Being Tested
One of the possible options for the treatment of MS at present is a high-do...
Status
Recruiting
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2020-10-01
Trial ID
NCT05832515
Treatments Being Tested
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Status
Completed
Location
Hunan Cancer hospital
Start Date
2019-07-01
Trial ID
NCT05942768
Treatments Being Tested